The Mechanism of Tigecycline Resistance in Acinetobacter baumannii Revealed by Proteomic and Genomic Analysis
International Journal of Molecular Sciences · 12.05.2023 · 24 (10) · 8652
DOI: 10.3390/ijms24108652 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 12.05.2023. Verfasst von Cunwei Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University, Beijing 100191, China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Acinetobacter baumannii. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Natural Science Foundation of China to QHZ.
Abstract (Originalsprache)
The mechanism of tigecycline resistance in A. baumannii remains largely unclear. In this study, we selected a tigecycline-resistant and a tigecycline-susceptible strain from a tigecycline-susceptible and a resistant strain, respectively. Proteomic and genomic analyses were performed to elucidate the variations associated with tigecycline resistance. Our study showed proteins associated with efflux pump, biofilm formation, iron acquisition, stress response, and metabolic ability are upregulated in tigecycline resistant strains, and efflux pump should be the key mechanism for tigecycline resistance. By genomic analysis, we found several changes in the genome that can explain the increased level of efflux pump, including the loss of the global negative regulator hns in the plasmid and the disruption of the hns gene and acrR gene on the chromosome by the insertion of IS5. Collectively, we not only revealed the phenomenon that the efflux pump is mainly responsible for tigecycline resistance, but also highlighted the mechanism at the genomic level, which will help in understanding the resistance mechanism in detail and provide clues for the treatment of clinical multiple drug-resistant A. baumannii.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University, Beijing 100191, China.
- State Key Laboratory of Communicable Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention…
Förderung
- National Natural Science Foundation of China
- National Natural Science Foundation of China to QHZ
Zitieren
APA
Liu, C., Wang, L., Wang, P., Xiao, D., & Zou, Q. (2023). The Mechanism of Tigecycline Resistance in Acinetobacter baumannii Revealed by Proteomic and Genomic Analysis. International Journal of Molecular Sciences, 24(10), 8652. https://doi.org/10.3390/ijms24108652
Vancouver
Liu C, Wang L, Wang P, Xiao D, Zou Q. The Mechanism of Tigecycline Resistance in Acinetobacter baumannii Revealed by Proteomic and Genomic Analysis. International Journal of Molecular Sciences. 2023;24(10):8652. doi:10.3390/ijms24108652
BibTeX
@article{Liu2023,
author = {Liu, Cunwei and Wang, Lei and Wang, Ping and Xiao, Di and Zou, Qinghua},
title = {The Mechanism of Tigecycline Resistance in Acinetobacter baumannii Revealed by Proteomic and Genomic Analysis},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {10},
pages = {8652},
doi = {10.3390/ijms24108652}
}
EUVIMED